Altogether, these results strongly support the idea that HMGA1P7 could act as ceRNAs in human breast cancer and represent a novel potential mechanism accounting for H19 and IGF2 upregulation in these tumors. This evidence concerns the gene HMGA1P7 and breast cancer.